Minimal change disease and focal segmental glomerulosclerosis

被引：18
|
作者：
Fogo, AB [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2001年 / 16卷
关键词：
D O I：
10.1093/ndt/16.suppl_6.74
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：74 / 76
页数：3
相关论文
共 50 条
  • [31] The nonspecificity of focal segmental glomerulosclerosis - The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change
    McAdams, AJ
    Valentini, RP
    Welch, TR
    MEDICINE, 1997, 76 (01) : 42 - 52
  • [32] GLOMERULOMEGALY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) BUT NOT MINIMAL CHANGE GLOMERULOPATHY (MCG)
    JENNETTE, JC
    MARQUIS, A
    FALK, RJ
    BODICK, N
    LABORATORY INVESTIGATION, 1990, 62 (01) : A48 - A48
  • [33] Sox9 Potentially Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease
    Braunhut, Beth L.
    Cracolici, Vincent M.
    Henriksen, Kammi J.
    Cajaiba, Mariana M.
    Chang, Anthony
    MODERN PATHOLOGY, 2017, 30 : 405A - 405A
  • [34] The study of urinary CD80 in children with minimal change disease and focal segmental glomerulosclerosis
    Chen, L.
    Xiaorong, L.
    Ying, S.
    Zhi, C.
    Jianfeng, F.
    Yeping, J.
    Qun, M.
    PEDIATRIC NEPHROLOGY, 2014, 29 (12) : 2436 - 2437
  • [35] A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease
    Cambier, Alexandra
    Patey, Natacha
    Royal, Virginie
    Gougeon, Francois
    Genest, Dominique S.
    Brachemi, Soumeya
    Bollee, Guillaume
    Merlen, Clemence
    Bonnefoy, Arnaud
    Lapeyraque, Anne-Laure
    Troyanov, Stephan
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (03): : 661 - 670
  • [36] Sox9 Potentially Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease
    Braunhut, Beth L.
    Cracolici, Vincent M.
    Henriksen, Kammi J.
    Cajaiba, Mariana M.
    Chang, Anthony
    LABORATORY INVESTIGATION, 2017, 97 : 405A - 405A
  • [37] The Spectrum of Minimal Change Disease/Focal Segmental Glomerulosclerosis: From Pathogenesis to Proteomic Biomarker Research
    Maslyennikov, Yuriy
    Barar, Andrada Alina
    Rusu, Crina Claudia
    Potra, Alina Ramona
    Tirinescu, Dacian
    Ticala, Maria
    Urs, Alexandra
    Pralea, Ioana Ecaterina
    Iuga, Cristina Adela
    Moldovan, Diana Tania
    Kacso, Ina Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [38] Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria
    Vinita Agrawal
    Narayan Prasad
    Manoj Jain
    Rakesh Pandey
    Clinical and Experimental Nephrology, 2013, 17 : 811 - 818
  • [39] A prospective study on complement activation distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease
    Cambier, Alexandra
    Patey, Natacha
    Royal, Virginie
    Brachemi, Soumeya
    Bollee, Guillaume
    Bonnefoy, Arnaud
    Laure, Lapeyraque Anne
    Troyanov, Stephan
    PEDIATRIC NEPHROLOGY, 2024, 39 (01) : S235 - S236
  • [40] Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria
    Agrawal, Vinita
    Prasad, Narayan
    Jain, Manoj
    Pandey, Rakesh
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (06) : 811 - 818
12345